A collaborative study by scientists from the La Jolla Institute for Immunology (LJI) and the University of Washington (UW) has shed light on a possible cause of lupus, suggesting that abnormal mutations within immune cells known as neutrophils could provoke the body's own defense mechanisms into attacking its healthy tissues.
These widespread mutations in neutrophils cause them to be perceived as threats by other immune cells. This internal conflict is believed to contribute to the severe inflammatory responses, chronic joint pain, and other debilitating symptoms characteristic of lupus throughout the body. Dr. Stephen Schoenberger, an LJI Professor and co-leader of this groundbreaking study published in Nature, remarked that this finding might unveil the fundamental pathology of the disease.
The scientists are still determining whether these mutated neutrophils are the direct cause of lupus, but they highlight that such a 'self-attack' is a defining feature of autoimmune conditions. The immune system's T cells and B cells normally target foreign invaders by recognizing specific peptides presented on cell surfaces. In lupus patients, however, researchers found peculiar 'splicing' mutations in the RNA of their neutrophils, leading to the creation of novel, 'foreign-looking' peptides. These neoantigens, when detected by T cells in the presence of inflammation, mistakenly signal danger, prompting an immune response against the body's own cells. Additionally, antibody-producing B cells were also observed to target these mutated neutrophils.
Autoimmune diseases are fundamentally characterized by the immune system attacking its own healthy tissues, leading to inflammation and organ damage. The new research suggests that mutated neutrophils might initiate this inflammatory cascade in lupus, although further investigation is required to confirm this hypothesis. This discovery introduces a novel perspective on the role of neutrophils in Systemic Lupus Erythematosus (SLE), emphasizing the complex interplay of autoantibodies, immune complexes, nucleic acids, and interferons. The central question now is whether these neoantigens are a primary cause or a consequence of the ongoing inflammatory processes.
This study also supports the 'neoantigen hypothesis' of autoimmunity, which posits that the immune system, rather than failing in its tolerance, is acting precisely as designed by targeting what it perceives as foreign, even when those targets are self-derived. This new understanding offers a vital clue for advancing research and developing treatments for autoimmune diseases, ultimately moving towards a future where such debilitating conditions can be managed more effectively, fostering hope and improved well-being for affected individuals.